Hannah Barry (nee Pearce) currently serves as the Global Head of Medical Affairs Clinical Operations at Ipsen since February 2024. Prior to this role, Hannah was the VP and Head of Clinical Operations at Silence Therapeutics plc from January 2022 to February 2024. Hannah has extensive experience at GSK from October 2012 to January 2022, where positions included Implementation Director and Head of Immunoinflammation & Fibrosis within Global Clinical Sciences and Delivery, as well as leading various roles focused on clinical operations. Hannah began their career in clinical research at Merck Serono, where Hannah held multiple leadership roles over nearly a decade, and further experience includes working at Pfizer and Covance. Hannah holds an MSc in Clinical Research from Cardiff University and a BSc (Hons) in Biomedical Sciences from the University of Bradford.
This person is not in any teams
This person is not in any offices